Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Non Operating Income (2016 - 2025)

iBio (IBIO) has disclosed Non Operating Income for 16 consecutive years, with $452000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 721.82% to $452000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $736000.0, a 44.49% decrease, with the full-year FY2025 number at $225000.0, down 81.11% from a year prior.
  • Non Operating Income was $452000.0 for Q4 2025 at iBio, up from $231000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $9.6 million in Q2 2021 to a low of -$459000.0 in Q1 2021.
  • A 5-year average of $570350.0 and a median of $41000.0 in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: skyrocketed 1663.5% in 2021, then tumbled 361.9% in 2023.
  • iBio's Non Operating Income stood at $40000.0 in 2021, then plummeted by 75.0% to $10000.0 in 2022, then fell by 20.0% to $8000.0 in 2023, then soared by 587.5% to $55000.0 in 2024, then surged by 721.82% to $452000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Non Operating Income are $452000.0 (Q4 2025), $231000.0 (Q3 2025), and $35000.0 (Q2 2025).